Chris Tower has been chosen to replace retiring General Manager Guy Woodman at Euromed USA
Euromed, a producer of standardised herbal extracts, is pleased to announce the appointment of industry veteran Chris Tower to the position of General Manager of its key subsidiary Euromed USA. Tower will replace current General Manager Guy Woodman, who will be retiring later this year. Tower is a highly experienced, senior level executive with an extensive range of skills and more than 25 years of successful sales, business development and operations expertise in the US and global botanical extract industry.
Tower has previously held key management positions with an array of leading botanical extract manufacturers, including serving as VP of Sales and Marketing of Sensient Natural Extracts (formally Mazza Innovation), founding President and CEO of Layn USA. (subsidiary of Layn Natural Ingredients Corp.) and VP Sales and Business Development for leading Italian and German botanical extract manufacturers.
We took more than a year to find the ideal candidate to fill this vital role
“We are very happy to have Chris join our team,” said Javier Roig, General Manager of Euromed. “He is a proven leader with extensive knowledge of our industry on every level, and we look forward to his leadership for years to come.”
Guy Woodman, outgoing General Manager of Euromed USA, added: “We took more than a year to find the ideal candidate to fill this vital role, and I feel totally comfortable handing over the reins to Chris as I know the company will be in very capable hands.”
“I highly value the level of careful consideration Euromed invested in the selection process, and it is my great pleasure and honour to join this exceptional company which I’ve admired and respected throughout my career,” says Chris. “I could not be more excited, not to mention proud, to join Euromed – an organisation which I know to be deeply rooted in quality and devoted to continuous innovation.”